Business Context and Reporting Period
This Form 8-K is a current report filed by Integer Holdings Corporation (ITGR) on June 24, 2026. The filing addresses Item 5.02 regarding the departure of certain officers and changes to compensatory arrangements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive personnel changes and does not contain financial performance data.
Material Changes
The primary material change is the transition of Jim Stephens from President, Cardiac Rhythm Management & Neuromodulation, to Executive Vice President, Special Projects, effective June 29, 2026. A letter agreement dated June 26, 2026, establishes a termination date of March 31, 2027, for this new role.
Guidance, Outlook, and Management Commentary
- Compensation Changes: Mr. Stephens will not be eligible for short-term or long-term incentive awards in 2027.
- Change of Control Provisions: If a Change of Control occurs on or prior to the Termination Date and Mr. Stephens remains employed through that date, his separation will be considered a termination without Cause under the Amended and Restated Change of Control Agreement dated May 22, 2026.
- Other Terms: All other terms and conditions of his employment remain unchanged.
Investor Verification Checklist
- Verify the specific terms of the Amended and Restated Change of Control Agreement dated May 22, 2026, to understand potential severance liabilities.
- Confirm the operational impact of removing Mr. Stephens from the Cardiac Rhythm Management & Neuromodulation leadership role.
- Review the Company's 2027 compensation plan to assess the financial impact of excluding Mr. Stephens from incentive awards.